131 related articles for article (PubMed ID: 18602954)
1. A new living cell-based assay system for monitoring genome-length hepatitis C virus RNA replication.
Dansako H; Ikeda M; Abe K; Mori K; Takemoto K; Ariumi Y; Kato N
Virus Res; 2008 Oct; 137(1):72-9. PubMed ID: 18602954
[TBL] [Abstract][Full Text] [Related]
2. New efficient replication system with hepatitis C virus genome derived from a patient with acute hepatitis C.
Mori K; Abe K; Dansako H; Ariumi Y; Ikeda M; Kato N
Biochem Biophys Res Commun; 2008 Jun; 371(1):104-9. PubMed ID: 18406345
[TBL] [Abstract][Full Text] [Related]
3. [Replication of hepatitis C virus genome].
Kato N
Uirusu; 2008 Dec; 58(2):191-8. PubMed ID: 19374197
[TBL] [Abstract][Full Text] [Related]
4. Application of the trak-C HCV core assay for monitoring antiviral activity in HCV replication systems.
Cagnon L; Wagaman P; Bartenschlager R; Pietschmann T; Gao T; Kneteman NM; Tyrrell DL; Bahl C; Niven P; Lee S; Simmen KA
J Virol Methods; 2004 Jun; 118(1):23-31. PubMed ID: 15158065
[TBL] [Abstract][Full Text] [Related]
5. Hydroxyurea as an inhibitor of hepatitis C virus RNA replication.
Nozaki A; Morimoto M; Kondo M; Oshima T; Numata K; Fujisawa S; Kaneko T; Miyajima E; Morita S; Mori K; Ikeda M; Kato N; Tanaka K
Arch Virol; 2010 Apr; 155(4):601-5. PubMed ID: 20204428
[TBL] [Abstract][Full Text] [Related]
6. Different anti-HCV profiles of statins and their potential for combination therapy with interferon.
Ikeda M; Abe K; Yamada M; Dansako H; Naka K; Kato N
Hepatology; 2006 Jul; 44(1):117-25. PubMed ID: 16799963
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of action of ribavirin in a novel hepatitis C virus replication cell system.
Mori K; Ikeda M; Ariumi Y; Dansako H; Wakita T; Kato N
Virus Res; 2011 Apr; 157(1):61-70. PubMed ID: 21320556
[TBL] [Abstract][Full Text] [Related]
8. Plural assay systems derived from different cell lines and hepatitis C virus strains are required for the objective evaluation of anti-hepatitis C virus reagents.
Ueda Y; Mori K; Ariumi Y; Ikeda M; Kato N
Biochem Biophys Res Commun; 2011 Jun; 409(4):663-8. PubMed ID: 21620801
[TBL] [Abstract][Full Text] [Related]
9. A recombinant replication-competent hepatitis C virus expressing Azami-Green, a bright green-emitting fluorescent protein, suitable for visualization of infected cells.
Hou W; Aoki C; Yu L; Wen X; Xue Y; Gao B; Liu W; Gao GF; Iwamoto A; Kitamura Y
Biochem Biophys Res Commun; 2008 Dec; 377(1):7-11. PubMed ID: 18786508
[TBL] [Abstract][Full Text] [Related]
10. High-throughput screening of HCV RNA replication inhibitors by means of a reporter replicon system.
Hao W; Duggal R
Methods Mol Biol; 2009; 510():243-50. PubMed ID: 19009266
[TBL] [Abstract][Full Text] [Related]
11. Cell culture-adaptive NS3 mutations required for the robust replication of genome-length hepatitis C virus RNA.
Abe K; Ikeda M; Dansako H; Naka K; Kato N
Virus Res; 2007 Apr; 125(1):88-97. PubMed ID: 17239465
[TBL] [Abstract][Full Text] [Related]
12. [The direct antiviral effect of interferon-gamma on hepatitis C virus replicon].
Jia YT; Wei L; Jiang D; Cong X; Fei R
Zhonghua Gan Zang Bing Za Zhi; 2006 Jan; 14(1):7-10. PubMed ID: 16420756
[TBL] [Abstract][Full Text] [Related]
13. Development of a simple system for screening anti-hepatitis C virus drugs utilizing mutants capable of vigorous replication.
Yu L; Aoki C; Shimizu Y; Shimizu K; Hou W; Yagyu F; Wen X; Oshima M; Iwamoto A; Gao B; Liu W; Gao GF; Kitamura Y
J Virol Methods; 2010 Nov; 169(2):380-4. PubMed ID: 20713089
[TBL] [Abstract][Full Text] [Related]
14. Screening for hepatitis C virus antiviral activity with a cell-based secreted alkaline phosphatase reporter replicon system.
Bourne N; Pyles RB; Yi M; Veselenak RL; Davis MM; Lemon SM
Antiviral Res; 2005 Aug; 67(2):76-82. PubMed ID: 15927278
[TBL] [Abstract][Full Text] [Related]
15. Antiviral action of interferon-alpha against hepatitis C virus replicon and its modulation by interferon-gamma and interleukin-8.
Jia Y; Wei L; Jiang D; Wang J; Cong X; Fei R
J Gastroenterol Hepatol; 2007 Aug; 22(8):1278-85. PubMed ID: 17565587
[TBL] [Abstract][Full Text] [Related]
16. Oncostatin M synergistically inhibits HCV RNA replication in combination with interferon-alpha.
Ikeda M; Mori K; Ariumi Y; Dansako H; Kato N
FEBS Lett; 2009 May; 583(9):1434-8. PubMed ID: 19332062
[TBL] [Abstract][Full Text] [Related]
17. The non-immunosuppressive cyclosporin DEBIO-025 is a potent inhibitor of hepatitis C virus replication in vitro.
Paeshuyse J; Kaul A; De Clercq E; Rosenwirth B; Dumont JM; Scalfaro P; Bartenschlager R; Neyts J
Hepatology; 2006 Apr; 43(4):761-70. PubMed ID: 16557546
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive analysis of the effects of ordinary nutrients on hepatitis C virus RNA replication in cell culture.
Yano M; Ikeda M; Abe K; Dansako H; Ohkoshi S; Aoyagi Y; Kato N
Antimicrob Agents Chemother; 2007 Jun; 51(6):2016-27. PubMed ID: 17420205
[TBL] [Abstract][Full Text] [Related]
19. Serum-free cell culture system supplemented with lipid-rich albumin for hepatitis C virus (strain O of genotype 1b) replication.
Abe K; Ikeda M; Ariumi Y; Dansako H; Kato N
Virus Res; 2007 May; 125(2):162-8. PubMed ID: 17267063
[TBL] [Abstract][Full Text] [Related]
20. Mizoribine inhibits hepatitis C virus RNA replication: effect of combination with interferon-alpha.
Naka K; Ikeda M; Abe K; Dansako H; Kato N
Biochem Biophys Res Commun; 2005 May; 330(3):871-9. PubMed ID: 15809077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
